Rheumatic and muskuloskeletal diseases (RMDs) are among the biggest causes of work loss in Europe. Achieving influence in policies that shape the lives of people with rheumatic and musculoskeletal diseases (RMDs) require vigorous efforts.
The Time2Work campaign was launched to mark World Arthritis Day in 2019.
Why it matters
To help people with RMDs access work for the first time, remain in work when they develop an RMD, or return to work after rehabilitation, and to promote the adoption of other initiatives that not only help people with RMDs, but all workers.
'A day in the life'
EULAR, follows four people from different European countries on their daily journey in the working world. Addressing challenges and how to find solutions to problems is part of the everyday life of the four individuals, who each live with the devastating effects of different rheumatic and musculoskeletal diseases (RMDs).
Join them and be inspired from both the employee and employer perspective.
Peter Boyd, who is living with rheumatoid arthritis and fibromyalgia, both rheumatic and musculoskeletal diseases (RMDs) in Ireland.
Despo Charalambous Demetriou, who is living with systemic sclerosis, a rheumatic and musculoskeletal disease (RMD) in Nicosia, Cyprus.
Lyubomir Ivanchev, living with the rheumatic and musculoskeletal disease, psoriatic arthritis, in Sofia, Bulgaria.
Rosário Morujão, who is living with Sjogren's Syndrome, a rheumatic and musculoskeletal disease (RMD) in Lisbon, Portugal.
Join the campaign
This resource is aimed at people with rheumatic and musculoskeletal diseases (RMDs) and provided to national organisations of PARE by EULAR as part of the Don’t Delay, Connect Today Time2Work campaign. The materials in this resource are provided in English but can also be adapted and translated by your organisation for use in your country.
EULAR has ongoing campaigns in order to achieve the goal set under the EULAR Strategy 2023 under advocacy, to increase participation in work by people with RMDs. Read more EULAR Strategy
EULAR’s Advocacy efforts are focused on bringing the needs of the rheumatology community to the attention of European political stakeholders at the European Union and national levels. EULAR Advocacy is working to ensure that health, employment and research policy, legislation and regulation, and programmes, are focused on improving the treatment, prevention and rehabilitation of RMDs and reducing the burden of RMDs on individuals and society.